Granahan Investment Management, LLC

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1026710 WALTHAM, MA

Position in BBIO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$7,642,170

-$144,894 QoQ

Shares Held

102,911

+1.1% QoQ

Ownership

0.053%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

9 quarters on record

Voting authority Sole 88.72812430158098.ToString("F0")% Shared 0.ToString("F0")% None 11.271875698419022.ToString("F0")%

Healthcare · as of Mar 31, 2026

Granahan Investment Management, LLC holds $141,409,593 across 24 Biotechnology names. BBIO ranks #5 (5.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	STOK	Stoke Therapeutics, Inc.	335,586	$10,926,680
2	VKTX	Viking Therapeutics, Inc.	332,192	$10,809,527
3	CELC	Celcuity Inc.	88,833	$10,139,398
4	SRRK	Scholar Rock Holding Corp	156,314	$7,684,396
5	BBIO	BridgeBio Pharma, Inc. This page	102,911	$7,642,170
6	SNDX	Syndax Pharmaceuticals Inc	306,321	$7,155,658
7	RYTM	Rhythm Pharmaceuticals, Inc.	77,709	$6,758,351
8	IMNM	Immunome Inc.	307,021	$6,714,549

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,642,170	102,911	+1.1%	Shares	Sole	2026-05-15
2025-12-31	$7,787,064	101,805	-36.9%	Shares	Sole	2026-02-17
2025-09-30	$8,376,779	161,278	+95.0%	Shares	Sole	2025-11-14
2025-06-30	$3,570,554	82,690	-55.0%	Shares	Sole	2025-08-14
2024-09-30	$4,679,242	183,788	-26.9%	Shares	Sole	2024-11-14
2024-06-30	$6,371,128	251,525	-45.0%	Shares	Sole	2024-08-14
2024-03-31	$14,130,007	456,986	+17.7%	Shares	Sole	2024-05-15
2023-12-31	$15,675,751	388,302	+256.8%	Shares	Sole	2024-02-14
2023-09-30	$2,869,609	108,821	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.